Conventional radiology and computed tomography in ovarian cancer: discussion paper! R M Blaquiere BSC FRCR Janet E Husband MRCP FRCR Royal Marsden Hospital and Institute of Cancer Research. Sutton. Surrey Early symptoms in patients with ovarian cancer are usually few and nonspecific, many patients presenting with abdominal distension or a palpable mass due to advanced disease. In these circumstances conventional radiology may assist in the initial diagnosis of ovarian cancer, but increasing emphasis is being placed on other techniques in the investigation of obscure masses. While ultrasound is now widely available, computed tomography is less so and with this in mind it is useful to consider the contribution of X-ray dependent examinations in ovarian cancer.
Conventional radiology
On a plain abdominal radiograph, a pelvic soft tissue mass may be visible and the finding of calcification is always significant. While the amorphous, well-circumscribed calcification of a uterine fibroid can usually be differentiated from the psammomatous calcification of the serous cystadenoma of cystadenocarcinoma, only 12% of these patients develop calcification in the primary tumour or its metastases (Lewis et al. 1982) (Figure 1 ). Some tumours rupture into the peritoneal cavity and the subsequent intraperitoneal masses calcify in a characteristic fashion -pseudomyxoma peritonei (Noonan 1969) . Soft tissue masses which contain dental elements, areas of fat or calcium density suggest an ovarian teratoma or dermoid. The demonstration of ascites and pleural effusions (which are frequently on the right in ovarian neoplasia) is a further clue to the diagnosis. Frequently, however, the plain radiograph is as nonspecific as the patient's symptoms.
In the presence of a palpable pelvic mass, contrast studies help to define the limits of the lesion and demonstrate local tumour invasion. Intravenous urography will differentiate the opacified bladder from an adjacent soft tissue mass, define the paths of the ureters for the surgeon, and demonstrate major renal tract involvement either by the primary tumour or by nodal metastases (Figure 2) . A barium enema, by demonstrating colonic displacement or infiltration, provides valuable information not only regarding the likely origin of abdominopelvic masses (Noonan 1969) but also helps to define direct or metastatic tumour spread.
Once a diagnosis of ovarian cancer has been established histologically, the use of lymphography varies at different centres, but our experience at the Royal Marsden Hospital suggests it is a valuable procedure. No other imaging method can demonstrate the nodal architecture and show metastases in normal-sized or minimally-enlarged nodes. Follow-up films are an essential part of the procedure and as many as 9% of Iymphograms only become positive during the initial follow-up period (Macdonald 1982) . Approximately 30% of patients with Stage III and 60% of patients with Stage IV disease have Iymphographicallydemonstrated nodal deposits. Rates of 8.6% and 11.8% have also been recorded in patients who would otherwise have been Stage I and II disease respectively (Musumeci et al. 1980 ). On occasions the lymphogram is the only radiological marker of disease and will provide a valuable index of progress or response to therapy. The simplicity of obtaining an abdominal radiograph makes this method of follow up both cheap and rapid. Computed tomography (CT) CT and ultrasound have revolutionized the demonstration of pelvic masses, and one of the challenges now is in deciding the correct place of the two techniques in the diagnosis and management of tumours such as ovarian cancer.
The problem presented to the radiologist is usually either 'What is the nature of the mass?' or 'What is its extent?' The accuracy of CT in determining the aetiology of a range of igure 3. Two ovarian tumours (arrows) occupying similar positions adjacent to the bladder (B). In A, the tumour IS of the same attenuation as the bladder contents (i.e. fluid-filled); while in B the tumour has uniform soft tissue attenuation (8). The attenuation of the cyst is very similar to that of the bladder contents (compare with Figure 3A) gynaecological masses varies between 60 and 75% (Amendola et al. 1981 , Sommer et al. 1982 , lack of separation of the uterus from the tumour masking the aetiology in a number of cases. The pelvic masses found in ovarian cancer range from the predominantly cystic lesion to the uniformly solid ( Figure 3) . A mixed cystic/solid pattern with or without septa is common. The presence of a septate mass is an important clue to an ovarian aetiology and, while CT will often demonstrate septa, they are frequently more readily shown by ultrasound (Araki et al. 1982) . Coarse, ill-defined calcification within the tumour (Figure 4 ) is shown better by CT than by conventional radiology and calcification in metastases also may be seen, particularly from mucinous tumours.
CT will not accurately predict the histological type of tumour (Mamtora & Isherwood 1982 )and on occasions cannot unequivocally differentiate malignant from benign masses. For example, a predominantly cystic carcinoma can look very similar to an ovarian cyst ( Figure  5 ). Some studies suggest that ultrasound is superior in the differentiation of benign from malignant ovarian tumours (Sommer et al. 1982) . The presence of ascites or associated metastatic spread will, or course, favour the diagnosis of malignancy, but the common CT appearance of a large mass of mixed attenuation with thick, irregular walls is usually diagnostic of a malignant tumour.
With the improved imaging of ovarian tumours, attempts are now being made to correlate the CT appearances with the standard systems of staging. Using the International Federation of Gynaecology and Obstetrics (FIGO) system, CT appears to be of most value in advanced disease, which is the stage at which most patients present. CT does not routinely demonstrate normal-sized or minimally-enlarged ovaries and therefore detection of Stage I . disease can be difficult. However, even small volumes of ascites can be shown by both CT and ultrasound, particularly around the liver margins, and these techniques can therefore be of value in late Stage I disease.
In Stage II disease we would hope to demonstrate a local mass and, in patients who have not' undergone hysterectomy, a mass which is inseparable from the uterus implies involvement. Local extension to bowel can be shown when this is fairly advanced and ureteric involvement is inferred from ureteric and renal pelvic dilatation ( Figure 6 ). The overall volume and extent of the tumour mass is accurately shown by CT, one of the main benefits being that the technique is not organ-or system-specific and can show involvement of a number of systems in a single examination.
In Stage III disease mesenteric masses (Figure 7) and peritoneal deposits can be demonstrated, while multiple tumour deposits in and around the omentum form an irregular omental cake beneath the anterior abdominal wall. CT will accurately demonstrate enlarged nodes due to metastases (Figure 8 ) but cannot demonstrate deposits in normal-sized nodes.
Since not all deposits cause nodal enlargement, lymphography has a distinct place in the investigation of these patients. Intraparenchymal liver deposits, said to occur in 10% of patients (Lewis et al. 1982) , are usually well shown as defined areas of low attenuation, occasionally with calcification.
Unfortunately, CT does have a major limitation in staging these patients, namely its inability to detect small-volume disease (i.e. less than 2-3 em) either within the peritoneum or in lymph nodes. This is particularly unfortunate in ovarian cancer, given this tumour's propensity to seed into the peritoneal cavity. The intraperitoneal fluid is thought to be pumped Figure 9 . Secondary deposits on the surface of the liver (arrows) Figure 10 . A large septate retrovesical ovarian tumour (A), showing marked diminution in size after three months of chemotherapy (B) superiorly, partly by the action of the diaphragm, and malignant cells tend to implant on the peritoneal surfaces including those of the liver. CT is notoriously poor at showing these deposits, particularly on the diaphragmatic surface of the liver, although they are better shown when ascites separates the liver from adjacent surfaces (Figure 9 ).
Thus, while CT is undoubtedly helpful in the diagnosis of ovarian cancer, its inability to detect small-volume disease, the need for histological confirmation and for accurate staging make a laparotomy unavoidable. It is therefore debatable whether CT, given its relative expense and the limited scanning time available, should be used for the initial evaluation of suspected ovarian tumours.
After staging laparotomy, the value of CT is threefold: (1) As an additional staging procedure: We have seen occasional patients who have had liver metastases only revealed by CT. Johnson et al. (1983) report 6 patients in whom CT, performed within three weeks of the staging laparotomy, detected intraparenchymal hepatic metastases not seen surgically. The same authors also report uterine invasion shown by CT but not at staging laparotomy. These findings have obvious therapeutic implications.
(2) Assessing residual tumour volume; The amount of tumour removed varies according to the surgical difficulties encountered and the remaining volume can have therapeutic and prognostic significance. CT should accurately define the volume and extent of the residual mass. Not only does this provide a useful baseline study but can also assist in radiotherapy planning.
(3) Assessing tumour response to therapy: This response is, of course, extremely variable but can be dramatic ( Figure 10) . Information provided by CT should help in either modification of therapy or in the timing of second-look surgery. In patients thought to be in complete remission, CT has proved valuable in detecting recurrent masses which may be impalpable on clinical examination and CT is probably more accurate than clinical examination in assessing pelvic side wall involvement, particularly in patients who have had previous radiotherapy (Photopoulos et al. 1979 ). However, ultrasound has an accuracy very similar to that of CT in both detecting and excluding recurrent pelvic tumours and hepatic metastases (Cosgrove et al. 1980 ).
If we accept the limitations of CT in staging, which at the moment appear insuperable and make a staging laparotomy mandatory, it appears that CT finds its most valuable application in this type of post-Iaparotomyjfollow-up study. It is, however, relatively expensive and there is a great deal. of pressure for CT space. If, as seems likely, CT and ultrasound provide similar information in the evaluation of patients with primary or recurrent pelvic tumours (Sanders et al. 1983) , then it may well be best to reserve CT for those cases where ultrasound is technically difficult or the result is equivocal.
